Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-492318
Filing Date
2016-03-04
Accepted
2016-03-04 07:27:35
Documents
3
Period of Report
2016-03-04

Document Format Files

Seq Description Document Type Size
1 6-K d155900d6k.htm 6-K 10373
2 EX-99.1 d155900dex991.htm EX-99.1 7495
3 GRAPHIC g155900g78k79.jpg GRAPHIC 9468
  Complete submission text file 0001193125-16-492318.txt   31984
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 161483581
SIC: 2834 Pharmaceutical Preparations